Valentine M. Brousse

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

Journal: American journal of hematology

Published: April 19, 2026

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

Journal: American journal of hematology

Published: January 13, 2026

Identification of predictive factors for reversal of cerebral vasculopathy in an original longitudinal cohort study in newborns with sickle cell anaemia.

Identification of predictive factors for reversal of cerebral vasculopathy in an original longitudinal cohort study in newborns with sickle cell anaemia.

Journal: British journal of haematology

Published: January 12, 2026

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere

Published: November 26, 2025

Nasopharyngeal Carriage and Antibiotic Resistance in Children With Sickle Cell Disease: The DREPANOBACT French Multicenter Prospective Study.

Nasopharyngeal Carriage and Antibiotic Resistance in Children With Sickle Cell Disease: The DREPANOBACT French Multicenter Prospective Study.

Journal: The Pediatric infectious disease journal

Published: April 15, 2025

Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease.

Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease.

Journal: American journal of hematology

Published: April 04, 2025

What's wrong with drug development for sickle cell disease?

What's wrong with drug development for sickle cell disease?

Journal: HemaSphere

Published: November 26, 2024

Comparative histological analysis of spleens in pediatric patients with hemolytic anemias: Insights into the pathophysiological mechanisms of spleen destruction in sickle cell anemia.

Comparative histological analysis of spleens in pediatric patients with hemolytic anemias: Insights into the pathophysiological mechanisms of spleen destruction in sickle cell anemia.

Journal: American journal of hematology

Published: February 09, 2024

Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study.

Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: January 23, 2024

Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.

Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.

Journal: American journal of hematology

Published: November 05, 2023

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Journal: Haematologica

Published: September 20, 2023

Global burden of sickle cell disease in 2021.

Global burden of sickle cell disease in 2021.

Journal: The Lancet. Haematology

Published: July 21, 2023

Showing 1-12 of 102

Last Updated: 09/26/2026